Client
- Description
- Advocacy organization for the biotechnology industry.
- Location
- District of Columbia · United States of America
Registrant
- Firm
- DLA PIPER LLP (US)
- Description
- Law firm.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
4 issuesMedical/Disease Research/Clinical Labs
Issues related to PAHPA reauthorization. Rare Pediatric Disease Priority Review Voucher Program reauthorization. Issues related to drug pricing and value generally. Issues related to pharmacy benefit managers and reporting requirements. 340B. Orphan drugs. Supply chain. Vaccine policy. Issues related to FDA, drug development, and clinical trial requirements.
Lobbyistsmr JAMIE ALEXEI GREGORIAN · MARGARET MARTIN · RACHEL PORTMAN · KARINA LYNCH · RICHARD BURR · VINCENT SARUBBI jr
TargetedSENATE · HOUSE OF REPRESENTATIVES · Food & Drug Administration (FDA)
Health Issues
Issues related to PAHPA reauthorization. Rare Pediatric Disease Priority Review Voucher Program reauthorization. Issues related to drug pricing and value generally. Issues related to pharmacy benefit managers and reporting requirements. 340B. Orphan drugs. Supply chain. Vaccine policy. Issues related to FDA, drug development, and clinical trial requirements.
Lobbyistsmr JAMIE ALEXEI GREGORIAN · MARGARET MARTIN · RACHEL PORTMAN · KARINA LYNCH · RICHARD BURR · VINCENT SARUBBI jr
TargetedSENATE · HOUSE OF REPRESENTATIVES · Food & Drug Administration (FDA)
Medicare/Medicaid
Issues related to reimbursement under Medicare Part B and Part D. Medicare and Medicaid payment and coverage issues. IRA implementation.